UK Court Clarifies Obviousness Rule In Levaquin Suit

By Tina Peng (July 6, 2009, 12:00 AM EDT) -- A U.K. appeals court has upheld a determination of validity for Daiichi Pharmaceutical Co.'s patent for the active ingredient in the antibiotic Levaquin, ruling that an invention is not obvious if the course of action is obvious but a skilled person would not have the motivation to pursue it to the point of invention....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!